Pharmaceuticals Government Tenders in France

Registration, quality assurance and the shape of a medicines contract

A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programmes -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.

Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.

The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and programme funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.

This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.

Who buys pharmaceuticals in France?

GlobalGov holds 2,277 pharmaceuticals records from 1,424 distinct buying organisations in France. The most frequent publishers are Partenord Habitat (21 records); siaap (13 records); Commissariat à l'énergie atomique et aux énergies alternatives (10 records); ville de Paris (9 records); collectivite de corse (8 records); troyes Champagne Métropole (8 records). Between them the 6 largest account for 3.0% of everything published, so buying here is spread across many separate authorities.

What are pharmaceuticals contracts worth in France?

972 of the 2,277 records publish a contract value. The median is $1.2M and the largest single published value is $2.3B. By size, 40 under $100k, 403 between $100k and $1M, 397 between $1M and $10M, 132 above $10M. The remaining 1,305 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.

How long do bidders get to respond to pharmaceuticals tenders in France?

Across the 726 France pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 37 days. A quarter of them allowed 32 days or fewer and a quarter stayed open for more than 46. Not one of them closed within a fortnight of being published, so the window on this market is consistently workable.

How often are pharmaceuticals tenders published in France?

France publishes about 17 notices a month in this category, 199 in the last twelve months. That is 51% fewer than the 403 published in the twelve months before that. Over the last three years there were 1,024, spread across 63 separate months of activity since 6 July 2016. July is historically the busiest month. The most recent was published 31 August 2026.

How does France compare with other pharmaceuticals markets?

Among the 39 countries where GlobalGov holds a comparable pharmaceuticals market, France ranks 5th by number of records. The largest is Germany (4,115 records against 2,277 here). Within France itself, pharmaceuticals is the 29th largest of the 86 procurement categories tracked here.

Where do the France pharmaceuticals records on this page come from?

These 2,277 records are collected from 2 official sources: TED (2,224), BOAMP (53). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-10-01.

Open Pharmaceuticals tenders in France

Showing 3 of the 3 notices open in this category today. Openness uses the same definition as the France market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.

Other procurement categories in France

Pharmaceuticals procurement in other markets